Anti-Mos [R38.1]
Invented by Julian Gannon from The Francis Crick Institute
Invented at Cancer Research UK London Research Institute: Clare Hall Laboratories
- Datasheet
- References (2)
- Inventor Info
Info
| Catalogue Number | 151018 |
| Applications | ELISA WB |
| Antigen/Gene or Protein Targets | Mos |
| Reactivity | Xenopus laevis |
| Relevance | MOS (or CSF) is a mitogen-activated protein kinase kinase kinase (MAP3K) that is present in eggs during meiosis. It is destroyed after exit from meiosis II before fertilisation. It provides a good marker for studies of oocytes during oogenesis and maturation. |
| Host | Mouse |
| Immunogen | MBP-mos fusion protein. |
| Subclass | IgG2b |
| Myeloma Used | Sp2/0-Ag14 |
| Recommended Growing Conditions | DMEM + 5% FCS |
| Research Area | Cancer, Cell Type or Organelle Marker, Cell Signaling & Signal Transduction, Developmental Biology, Epigenetics & Nuclear Signalling, Stem Cell Biology |
References: 2 entries
Nebreda et al. 1995. EMBO J. 14(22):5597-607. PMID: 8521817.
Newly synthesized protein(s) must associate with p34cdc2 to activate MAP kinase and MPF during progesterone-induced maturation of Xenopus oocytes.
Europe PMC ID: 8521817
Add a reference
References: 2 entries
Nebreda et al. 1995. EMBO J. 14(22):5597-607. PMID: 8521817.
Newly synthesized protein(s) must associate with p34cdc2 to activate MAP kinase and MPF during progesterone-induced maturation of Xenopus oocytes.
Add a reference
